Centre flags semaglutide rules in India's weight-loss journey
Without domestic standards, Indian manufacturers have been relying on internal protocols or foreign manuals to manufacture weight-loss drugs, a market that CareEdge expects to cross $347 million in India sales by 2035.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)